e-journal

ANYTHING TO STAY ALIVE: THE CHALLENGES OF A CAMPAIGN FOR AN EXPERIMENTAL DRUG

---

ABSTRACT:
Drug-resistant tuberculosis (TB) has a high mortality rate. Most medicines used to treat it are poorly tested and have terrible side effects. Activists have campaigned for patients with drug-resistant TB to have access to experimental drugs, particularly one called bedaquiline, before these have been approved by regulatory authorities such as the Food and Drug Administration (FDA) in the United States (US) and the Medicines Control Council (MCC) in South Africa. Some activists have also campaigned for bedaquiline to be approved by regulatory authorities before testing of the drug is completed. These campaigns raise ethical concerns about whether patients should be offered experimental, unapproved, medicines for the
treatment of life-threatening illnesses, and if authorities should approve drugs for life-threatening illnesses when vital questions about safety and
efficacy remain outstanding.

---

Ketersediaan

Tidak ada salinan data

Informasi Detail

Judul Seri

Developing World Bioethics

No. Panggil

-

Penerbit

: Developing World Bioethics., 2016

Deskripsi Fisik

Developing World Bioethics, Volume 16 Number 1 2016 pp 45–54

Bahasa

English

ISBN/ISSN

doi:10.1111/dewb.120

Klasifikasi

-

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

Volume 16 Number 1 2016

Subjek

DUNIA BIOETIKA

Info Detail Spesifik

-

Pernyataan Tanggungjawab

deliza

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar